ArticleInternational journal of clinical and experimental pathology2018

FOXM1 as a prognostic biomarker promotes endometrial cancer progression via transactivation of SLC27A2 expression.

Yichen Feng et al.PubMed ↗Full text ↗

No numbers read from the abstract.